from Canadian Broadcasting Corporation
Sunday, May 2, 2021
COVID-19 vaccine maker Providence says it s leaving Canada after calls for more federal support go unanswered
A volunteer receives an injection in this undated handout image provided by Providence Therapeutics. (Providence Therapeutics/The Canadian Press) The head of a homegrown company behind a promising COVID-19 vaccine says he s ready to pull his company out of Canada and take its product elsewhere after calls for more substantial federal support went unanswered. Brad Sorenson, the CEO of Calgary-based Providence Therapeutics, told CBC News he s had enough of the runaround from federal and provincial governments and he s working with the company s board of directors to move its operations overseas to focus on developing a vaccine for people in the southern hemisphere.
Winnipeg Free Press
Winnipeg operation would perform final mixing, packaging By: Dylan Robertson Save to Read Later
Emergent BioSolutions signed a contract late last year to produce a vaccine developed by Calgary-based Providence Therapeutics, which is pending approval. (Jesse Boily / Winnipeg Free Press files)
OTTAWA The federal industry minister says Ottawa has not turned its back on contributing to the expansion of a Winnipeg biomedical firm that hopes to produce COVID-19 vaccines.
OTTAWA The federal industry minister says Ottawa has not turned its back on contributing to the expansion of a Winnipeg biomedical firm that hopes to produce COVID-19 vaccines.
15 federal budget items Manitobans should know winnipegfreepress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from winnipegfreepress.com Daily Mail and Mail on Sunday newspapers.
Winnipeg Free Press By: Dylan Robertson
Emergent BioSolutions Winnipeg location.
OTTAWA The Trudeau government is sending mixed messages on whether it wants to shore up COVID-19 vaccine production in Winnipeg.
OTTAWA The Trudeau government is sending mixed messages on whether it wants to shore up COVID-19 vaccine production in Winnipeg.
The U.S. firm Emergent BioSolutions runs a facility near the University of Manitoba campus, and signed a contract late last year to produce a vaccine developed by Calgary-based Providence Therapeutics, which has financial support form the Pallister government but is still pending approval.
In an article published Monday, federal Industry Minister François-Philippe Champagne told the